We read with interest the recent controversial debate on probiotics for preterm infants sparked by the meta-analysis by Deshpande et al1 and associated commentaries by distinguished authors.2,3 Although we are supportive of the therapeutic potential of probiotics for exclusively formula-fed, very low birth weight neonates, none of the meta-analyses published to date have extracted data in relation to extremely preterm, extremely low birth weight infants or those exclusively fed breast milk. As such, we would be cautious about encouraging widespread use.We offer the following evidence base regarding associated confounders.For these reasons, we contend that more evidence is required before probiotics are accepted as an established therapy.
No takes yet. Share an insight, caveat, or question.
Beattie et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: